Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
基本信息
- 批准号:7599659
- 负责人:
- 金额:$ 5.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAmino AcidsArabidopsisBiochemicalBiochemical GeneticsBiological AssayCatalytic DomainCell NucleusCentromereChloroplastsChromatinChromosomal InstabilityCytosineDNADNA MethylationDNA Polymerase IDNA-Directed RNA PolymeraseDRD1 geneDataDefectDevelopmentDiseaseDouble-Stranded RNAEmbryoEscherichia coliEukaryotaEventFission YeastFragile X SyndromeGenesGeneticHealthHeterochromatinHumanLeadLightLinkMaintenanceMalignant NeoplasmsMediatingMethylationMethyltransferaseMitochondriaModificationMouse-ear CressNematodaNuclearNuclear RNAOrganismPaperPathway interactionsPhysical condensationPlantsPolymerasePrintingProcessProductionProteinsPublishingRNA DegradationRNA InterferenceRNA Interference PathwayRNA Polymerase IRNA chemical synthesisRNA-Directed RNA PolymeraseReportingResearchResearch PersonnelRetroelementsRetrotransposonRiceRoleSequence HomologsSmall Interfering RNASpecific qualifier valueTestingTranscriptTrisomyViralWorkchromatin modificationcombatds-DNAflygene therapygenetic resourcehistone modificationhuman DICER1 proteininsightmutantnovelprogramstool
项目摘要
DESCRIPTION (provided by applicant): In organisms as diverse as humans, flies, nematodes, fission yeast and plants, small interfering RNAs (siRNAs) regulate essential processes that include viral defense, silencing of retrotransposons, inactivation of specific mRNAs and centromere maintenance. The mechanisms by which siRNAs target homologous RNAs for degradation in Dicer and RISC-mediated RNA interference (RNAi) pathways are fairly well understood. By contrast, the mechanisms by which siRNAs direct histone modifications and/or cytosine methylation events that silence and maintain heterochromatic loci are poorly understood. A newly discovered activity required in the heterochromatic siRNA pathway in Arabidopsis thaliana is Nuclear RNA polymerase IV (pol IV). The two largest subunits of pol IV are similar to the catalytic subunits of E. coli DNA-dependent RNA polymerase and to the corresponding subunits of eukaryotic nuclear RNA polymerases I, II, and III. Disruption of pol IV subunits causes heterochromatin to disperse coincident with losses in cytosine methylation and siRNA production at repetitive genes and retrotransposons. The simplest hypothesis is that pol IV generates precursor transcripts for Dicer-generated siRNAs that direct heterochromatin modifications to homologous sequences. Interestingly, pol IV appears to lack conventional RNA polymerase activity using double-stranded DNA as the template. Pol IV largest subunits also have non- canonical amino acids at the presumptive active site, suggesting the hypothesis that pol IV has a novel polymerase activity. The finding that pol IV-dependent siRNA production also requires RNA-dependent RNA polymerase 2 (RDR2) and cytosine methyltransferase activity (DRM or MET1) suggests that double- stranded RNA or methylated DNA could be specialized templates transcribed by pol IV. The aims of the proposed research are: 1) To determine the templates, products and subunits of pol IV; 2) To deduce the step at which pol IV acts in the heterochromatic siRNA pathway and 3) To test the hypothesis that two distinct forms of pol IV act non-redundantly in contributing to global heterochromatin organization. Chromatin modifications are increasingly linked to siRNA involvement and are implicated in numerous cancers as well as Rett, ICF, Prader-Willi, Beckwith-Wiedemann and Fragile X syndromes. Chromosome instability, also linked to siRNA involvement at centromeres, can lead to trisomies or embryo lethality. Moreover RNA interference shows promise as a gene-therapy tool with which to combat disease. Our studies, which make use of Arabidopsis unique genetic resources, may therefore shed light on mechanisms of siRNA production and chromatin modification that have relevance to human health.
描述(由申请人提供):在像人类,苍蝇,线虫,裂变酵母和植物等多样的生物中,小型干扰RNA(siRNAS)调节了包括病毒防御的基本过程,包括病毒防御,沉默逆转转身,特定mRNA和特定mRNA和Centromere维护。 siRNA靶向同源RNA在dicer和RISC介导的RNA干扰(RNAI)途径中降解的机制已得到充分了解。相比之下,对siRNA的直接组蛋白修饰和/或胞嘧啶甲基化事件的机制却众所周知。拟南芥的异质siRNA途径中需要的新发现的活性是核RNA聚合酶IV(POL IV)。 POL IV的两个最大亚基类似于大肠杆菌DNA依赖性RNA聚合酶的催化亚基以及真核核RNA聚合酶I,II和III的相应亚基。 pol IV亚基的破坏会导致异染色质分散与重复基因和逆转座子的胞嘧啶甲基化和siRNA产生的损失一致。最简单的假设是,Pol IV生成了将异染色质修饰的dicer生成的siRNA的前体转录本。有趣的是,使用双链DNA作为模板,Pol IV似乎缺乏常规的RNA聚合酶活性。 Pol IV最大的亚基在假定活性位点也具有非典型的氨基酸,这表明POL IV具有新型聚合酶活性的假设。 POL IV依赖性siRNA的产生还需要RNA依赖性RNA聚合酶2(RDR2)和胞嘧啶甲基转移酶活性(DRM或MET1)的发现表明,POL IV转录的双链RNA或甲基化DNA可以专业化。拟议研究的目的是:1)确定POL IV的模板,产品和亚基; 2)推断POL IV在异型siRNA途径中起作用的步骤和3)检验以下假设:两种不同形式的Pol IV的两种形式在为全球异染色质组织贡献的情况下非重新起作用。染色质的修饰越来越多地与siRNA的参与有关,并与许多癌症以及RETT,ICF,Prader-Willi,Beckwith-Wiedemann和Fragile X综合征有关。染色体不稳定性也与centromeres的siRNA受累有关,可能导致trisomies或胚胎致死性。此外,RNA干扰显示了与疾病打击的基因治疗工具的希望。我们的研究利用了拟南芥独特的遗传资源,因此可以阐明与人类健康有关的siRNA生产和染色质修饰的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG Stuart PIKAARD其他文献
CRAIG Stuart PIKAARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG Stuart PIKAARD', 18)}}的其他基金
SPECIFICITY OF HISTONE ACETYLTRANSFERASE ENZYMES FROM ARABIDOPSIS THALIANA
拟南芥组蛋白乙酰转移酶的特异性
- 批准号:
7953917 - 财政年份:2009
- 资助金额:
$ 5.05万 - 项目类别:
SPECIFICITY OF HISTONE ACETYLTRANSFERASE ENZYMES FROM ARABIDOPSIS THALIANA
拟南芥组蛋白乙酰转移酶的特异性
- 批准号:
7721482 - 财政年份:2008
- 资助金额:
$ 5.05万 - 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
- 批准号:
8391724 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
- 批准号:
8204558 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
- 批准号:
8037901 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
SPECIFICITY OF HISTONE ACETYLTRANSFERASE ENZYMES FROM ARABIDOPSIS THALIANA
拟南芥组蛋白乙酰转移酶的特异性
- 批准号:
7355309 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
- 批准号:
7088118 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
- 批准号:
7220652 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
- 批准号:
9239452 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
- 批准号:
8041251 - 财政年份:2006
- 资助金额:
$ 5.05万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Actions of spiropyrimidinetriones against bacterial type II topoisomerases
螺嘧啶三酮对细菌 II 型拓扑异构酶的作用
- 批准号:
10750473 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Development of Selective Oxidative Biocatalytic Methods
选择性氧化生物催化方法的发展
- 批准号:
10606798 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10599654 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Enzymology of Bacteroides short and branched chain fatty acid metabolism
拟杆菌短链和支链脂肪酸代谢的酶学
- 批准号:
10651505 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Designing chemoenzymatic approaches to biologically active molecules enabled by enzyme library screening
通过酶库筛选设计生物活性分子的化学酶方法
- 批准号:
10723582 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别: